Li T, Cui Q, Liu S, Li Z, et al. Decitabine consolidation after CD19/CD22 CAR-T therapy as a novel maintenance treatment significantly improves survival outcomes in relapsed/refractory B-ALL patients. Leuk Res 2024;145:107569.
PMID: 39208598